Stroke Management Market Report 2025

The stroke management market size has grown strongly in recent years. It will grow from $40.24 billion in 2024 to $43.28 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to thrombolytic therapies, stroke prevention initiatives, rehabilitation techniques, telemedicine in stroke care, collaborative stroke networks.

The stroke management market size is expected to see strong growth in the next few years. It will grow to $58.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to emergence of neuroprotective therapies, artificial intelligence in stroke diagnosis, personalized medicine approaches, expanding access to acute care, global stroke care standardization. Major trends in the forecast period include advancements in medical imaging technology, telemedicine and remote monitoring, focus on preventive care and risk factor management, neuroprotective therapies and drug innovations, collaboration and multidisciplinary approaches.

The rising incidence of chronic diseases is expected to drive the growth of the stroke management market in the future. Chronic diseases are defined as conditions that persist for a year or longer and hinder daily activities, often requiring ongoing medical care. Stroke management plays a crucial role in supporting patients with various chronic conditions, such as cancer and cardiovascular diseases, by focusing on preventive care, education, and empowering patients, as well as developing integrated care delivery models that combine primary and secondary care. For instance, in August 2022, a report from the American College of Cardiology, a U.S.-based non-profit medical association, projected that all four major cardiovascular risk factors in the United States will increase from 2025 to 2060. Diabetes is expected to see the most significant rise, with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Additionally, substantial increases in cardiovascular disease rates are anticipated, including stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), with ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million) following closely. Therefore, the increasing incidence of chronic diseases is driving the growth of the stroke management market.

The increasing geriatric population is expected to drive the growth of the stroke management market in the future. The geriatric population includes individuals aged 65 and older, a demographic characterized by various biological, sociological, and psychological changes associated with aging. For example, in January 2024, the Population Reference Bureau, a U.S.-based nonprofit organization focused on collecting and providing statistics, projected that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, marking a 47% increase. Therefore, the growing geriatric population is a significant factor propelling the growth of the stroke management market.

Major companies in the stroke management market are increasingly focused on developing neurovascular technology to improve the diagnosis, treatment, and recovery processes for stroke patients. Neurovascular technology includes medical devices, techniques, and procedures aimed at diagnosing, treating, and managing conditions related to the brain's blood vessels and the nervous system. For example, in October 2022, Medtronic, an Ireland-based company specializing in medical technologies, launched a new platform designed to accelerate innovation in stroke care. This platform combines advanced imaging and data analytics to enhance decision-making, streamline workflows, and improve patient outcomes during stroke interventions. The new technology aims to equip clinicians with better tools for rapid diagnosis and treatment, facilitating timely interventions that can significantly mitigate the effects of strokes on patients.

Major players in the stroke management market are directing their efforts towards introducing innovative products, such as a portfolio of Ischemic stroke solutions, to gain a competitive advantage. An example is MicroVention Inc., a US-based neuroendovascular medical device company, which launched the Eric retrieval device for treating ischemic stroke in the US in June 2023. Eric, a self-expanding laser-cut clot retriever, features multiple retrieval cages on a pusher wire delivery system. MicroVention emphasizes the device's atraumatic design, following natural vessel guidelines to provide mild outward radial force, minimal vessel wall contact, and remarkable flexibility.

In December 2022, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Abiomed, Inc. This strategic move aimed to expand Johnson & Johnson's MedTech business growth, delivering cutting-edge medical innovations globally. Abiomed Inc., a US-based medical device technology company, specializes in developing and manufacturing stroke management devices, including heart pumps.

Major companies operating in the stroke management market include GE HealthCare Technologies Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, B Braun Melsungen AG, Bristol Myers Squibb Co., Cardinal Health Inc., Siemens Healthineers, Merck And Co. Inc., Asahi Intech Co. Ltd., Johnson & Johnson, Penumbra Inc., Teleflex Inc., Stryker Corporation, Biogen Inc., Bayer AG, Philips Healthcare, AstraZeneca Plc., F. Hoffmann-la Roche, Novartis AG, Takeda Pharmaceutical Company Ltd., Sanofi SA, Daiichi Sankyo Company Limited, Boehringer Ingelheim International GmbH, Pfizer Inc.

North America was the largest region in the stroke management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global stroke management market report during the forecast period. The regions covered in the stroke management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the stroke management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Stroke management involves the treatment administered when a blood vessel in the brain bursts or when something obstructs the blood flow to a specific area of the brain, resulting in the brain aging or sustaining damage.

The primary product categories within stroke management include diagnostics, drug therapy products, and interventional stroke management systems. Diagnostics pertain to procedures aimed at identifying a disease, ailment, or injury based on its symptoms and indications. These diagnostic tools find applications in various scenarios such as ischemic stroke and hemorrhagic stroke. Additionally, they cater to diverse end-users, including hospitals, clinics, ambulatory surgery centers, diagnostic centers, retail pharmacies, online pharmacies, and others.

The stroke management market research report is one of a series of new reports that provides stroke management market statistics, including stroke management industry global market size, regional shares, competitors with a stroke management market share, detailed stroke management market segments, market trends and opportunities, and any further data you may need to thrive in the stroke management industry. This stroke management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stroke management market includes revenues earned by entities by providing hyperacute care, acute care, rehabilitation, control of bleeding, and basic life support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.